12:00 AM
May 03, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Annamycin: Began Phase I/II testing

Aronex Pharmaceuticals Inc. (ARNX), The Woodlands, Texas
Product: Annamycin
Business: Cancer
Therapeutic category: Adjunct...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >